# LEVOTHYROXINE SODIUM

NDC: 70710-1835
Generic name: levothyroxine sodium
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20241101

FDA application: ANDA217066

## Active ingredients

- LEVOTHYROXINE SODIUM ANHYDROUS: 500 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1835"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1835
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf8a952c-f05b-4814-b55a-ed04be015269